Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

OptiNose

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Oslo, Norway Founded 2000 101-250 employees For Profit

OptiNose is a pharmaceutical company that develops and commercializes treatments for ear, nose, and throat (ENT) disorders.

OptiNose on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

OptiNose was acquired by Paratek Pharmaceuticals in 2025 for $330M.
Total Funding
$310.43M
Funding Rounds
8
Last Funding
Acquisitions
0
Monthly Visits
Contacts
160
Ticker
OPTN
NASDAQ

About OptiNose

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
OPTN
Exchange
NASDAQ
IPO date
Oct 13, 2017
Raised at IPO
$138M
Valuation at IPO
$604M

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Active products
18
IT spend
$534.84K

Company Info

Founded
2000
Employees
101-250
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
103
HQ
Oslo, Norway
Region
Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Exit date
Oct 13, 2017

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
1.4
Trend (90d)
-0.1
Last leadership hire
May 23, 2025

OptiNose Funding Rounds

8 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–5 of 8Show
Page 1 / 2

OptiNose Key People

Founder & CSO
VP and Chief Accounting Officer
CFO
Chief Executive Officer
Vice President, Business Development
160
professional contacts at OptiNose
Contact execs at OptiNose

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to OptiNose

Loading news…

FAQs about OptiNose

People who checked this page also checked these

Browse the full Acquirezy directory.